ERBB2 and gastric cancer: Chemotherapy is used for patients with advanced or recurrent GC and includes anti-vascular endothelial growth factor (anti-VEGF), anti-VEGF receptor, tyrosine kinase inhibitors, and Her2/Neu (also known as ErbB-2)-mediated pathway blockers 10, 11.